Deng, Q., Yang, H., Zhang, X., Chen, H., Qiu, Y., Wen, D., Xiong, X., Wang, W. and He, J. (2010) Correlation between Pre-Treatment Anemia and Prognosis in Non-Small Cell Lung Cancer Patients. Zhongguo Fei Ai Za Zhi, 13, 722-726.

has been cited by the following article:

• TITLE: Leucocytosis Predicts Survival in Metastatic Non Small Cell Lung Carcinoma Patients—A Retrospective Review of a Single Institution Data

  AUTHORS: Lamiae Amaadour, Zineb Benbrahim, Nadia Benaicha, Fatima Zahra Elmrabet, Samia Arifi, Chakib Nejjari, Nawfel Mellas

  KEYWORDS: Paraneoplastic Leucocytosis, NSCLC, Metastatic Stage, Survival

  JOURNAL NAME: Journal of Cancer Therapy, Vol.8 No.11, November 21, 2017

  ABSTRACT: Background: Tumor-related leukocytosis is a paraneoplastic syndrome that is encountered occasionally in the clinical course of patients with lung carcinoma. The aim of this study is to evaluate the prognostic significance of leucocytosis in patients with metastatic non small cell lung carcinoma. Methods: We retrospectively reviewed 205 cases of metastatic non small cell lung carcinoma diagnosed between January 2007 and December 2012 at the department of medical oncology, Hassan II University Hospital of Fez, Morocco. Clinical and laboratory data were collected including white blood cells at baseline. Leucocytosis was studied in relation to overall survival and progression free survival. Results: The frequency of leucocytosis was of 57.5%. Patients with leucocytosis had shorter overall survival (OS, p = 0.015) and disease-free survival (DFS, p 0.0001) than those without leucocytosis. In multivariable analysis, patients with leucocytosis had a significantly greater risk of death and recurrence than those without leucocytosis. Conclusion: Leucocytosis was valuable for predicting the prognosis of patients with metastatic non small cell lung carcinoma.